[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100620897":3},{"organization":4,"armGroups":7,"interventions":21,"overallOfficials":29,"centralContacts":33,"locations":40,"responsibleParty":265,"collaborators":38,"id":267,"slug":268,"hasResults":269,"nctId":270,"briefTitle":271,"officialTitle":272,"acronym":38,"eligibilityCriteria":273,"healthyVolunteers":269,"sex":274,"minAge":275,"maxAge":276,"enrollmentInfo":277,"targetDuration":38,"studyType":280,"phases":281,"briefSummary":283,"conditions":284,"keywords":38,"overallStatus":43,"whyStopped":38,"lastUpdateSubmitDate":287,"lastUpdatePostDateStruct":288,"startDateStruct":291,"completionDateStruct":293,"leadSponsor":295,"locationsCount":296},{"fullName":5,"class":6},"Merck Sharp & Dohme LLC","INDUSTRY",[8,14,18],{"label":9,"type":10,"description":11,"interventionNames":12},"Part 1 Prime Dose Escalation Panels","EXPERIMENTAL","Participants will receive single intravenous (IV) doses of MK-1045 at varying dose levels.",[13],"Biological: MK-1045",{"label":15,"type":10,"description":16,"interventionNames":17},"Part 2 Step-up Dose Escalation Panels","Participants will receive 3 step up doses of MK-1045 as a prime, step-up and target dose over a 3-week dosing interval.",[13],{"label":19,"type":10,"description":16,"interventionNames":20},"Part 3 Dose Expansion Panels (Optional)",[13],[22],{"type":23,"name":24,"description":25,"armGroupLabels":26,"otherNames":27},"BIOLOGICAL","MK-1045","IV infusion",[9,15,19],[28],"CN201",[30],{"name":31,"affiliation":5,"role":32},"Medical Director","STUDY_DIRECTOR",[34],{"name":35,"role":36,"phone":37,"phoneExt":38,"email":39},"Toll Free Number","CONTACT","1-888-577-8839",null,"Trialsites@msd.com",[41,59,74,87,102,115,130,143,156,170,185,197,207,214,228,242,255],{"facility":42,"status":43,"city":44,"state":45,"zip":46,"country":47,"countryCode":48,"cosmosGeoPoint":49,"geoPoint":54,"contacts":55},"Gold Coast University Hospital ( Site 1601)","RECRUITING","Southport","Queensland","4215","Australia","AU",{"type":50,"coordinates":51},"Point",[52,53],153.39796,-27.96724,{"lat":53,"lon":52},[56],{"name":57,"role":36,"phone":58,"phoneExt":38,"email":38},"Study Coordinator","+611300744284",{"facility":60,"status":43,"city":61,"state":62,"zip":63,"country":64,"countryCode":65,"cosmosGeoPoint":66,"geoPoint":70,"contacts":71},"Anima Diepenbeek ( Site 0601)","Diepenbeek","Limburg","3590","Belgium","BE",{"type":50,"coordinates":67},[68,69],5.41875,50.90769,{"lat":69,"lon":68},[72],{"name":57,"role":36,"phone":73,"phoneExt":38,"email":38},"+3211949115",{"facility":75,"status":43,"city":76,"state":77,"zip":78,"country":64,"countryCode":65,"cosmosGeoPoint":79,"geoPoint":83,"contacts":84},"UZ Gent ( Site 0602)","Ghent","Oost-Vlaanderen","9000",{"type":50,"coordinates":80},[81,82],3.71667,51.05,{"lat":82,"lon":81},[85],{"name":57,"role":36,"phone":86,"phoneExt":38,"email":38},"+3293322863",{"facility":88,"status":43,"city":89,"state":90,"zip":91,"country":92,"countryCode":93,"cosmosGeoPoint":94,"geoPoint":98,"contacts":99},"Chinese Academy of Medical Science Peking Union Medical College Hospital ( Site 1501)","Beijing","Beijing Municipality","100005","China","CN",{"type":50,"coordinates":95},[96,97],116.39723,39.9075,{"lat":97,"lon":96},[100],{"name":57,"role":36,"phone":101,"phoneExt":38,"email":38},"010-69151188",{"facility":103,"status":43,"city":104,"state":105,"zip":106,"country":92,"countryCode":93,"cosmosGeoPoint":107,"geoPoint":111,"contacts":112},"Union Hospital Tongji Medical College Huazhong University of Science and Technology ( Site 1504)","Wuhan","Hubei","430058",{"type":50,"coordinates":108},[109,110],114.26667,30.58333,{"lat":110,"lon":109},[113],{"name":57,"role":36,"phone":114,"phoneExt":38,"email":38},"027-84397521",{"facility":116,"status":43,"city":117,"state":118,"zip":119,"country":120,"countryCode":121,"cosmosGeoPoint":122,"geoPoint":126,"contacts":127},"Clinica de la Costa S.A.S. ( Site 0101)","Barranquilla","Atlántico","080020","Colombia","CO",{"type":50,"coordinates":123},[124,125],-74.78132,10.96854,{"lat":125,"lon":124},[128],{"name":57,"role":36,"phone":129,"phoneExt":38,"email":38},"+576053369999",{"facility":131,"status":43,"city":132,"state":133,"zip":134,"country":120,"countryCode":121,"cosmosGeoPoint":135,"geoPoint":139,"contacts":140},"Oncomédica S.A.S ( Site 0103)","Montería","Departamento de Córdoba","230002",{"type":50,"coordinates":136},[137,138],-75.87823,8.75081,{"lat":138,"lon":137},[141],{"name":57,"role":36,"phone":142,"phoneExt":38,"email":38},"+57 3106175733",{"facility":144,"status":43,"city":145,"state":146,"zip":147,"country":120,"countryCode":121,"cosmosGeoPoint":148,"geoPoint":152,"contacts":153},"Fundacion Valle del Lili ( Site 0102)","Cali","Valle del Cauca Department","760032",{"type":50,"coordinates":149},[150,151],-76.5199,3.43054,{"lat":151,"lon":150},[154],{"name":57,"role":36,"phone":155,"phoneExt":38,"email":38},"+573166237452",{"facility":157,"status":43,"city":158,"state":38,"zip":159,"country":160,"countryCode":161,"cosmosGeoPoint":162,"geoPoint":166,"contacts":167},"Arensia Exploartory Medicine ( Site 1301)","Tbilisi","0112","Georgia","GE",{"type":50,"coordinates":163},[164,165],44.83412,41.69143,{"lat":165,"lon":164},[168],{"name":57,"role":36,"phone":169,"phoneExt":38,"email":38},"+995568404374",{"facility":171,"status":43,"city":172,"state":173,"zip":174,"country":175,"countryCode":176,"cosmosGeoPoint":177,"geoPoint":181,"contacts":182},"Istituto Clinico Humanitas- IRCCS ( Site 1902)","Rozzano","Milano","20089","Italy","IT",{"type":50,"coordinates":178},[179,180],9.1559,45.38193,{"lat":180,"lon":179},[183],{"name":57,"role":36,"phone":184,"phoneExt":38,"email":38},"+390282247421",{"facility":186,"status":43,"city":187,"state":38,"zip":188,"country":175,"countryCode":176,"cosmosGeoPoint":189,"geoPoint":193,"contacts":194},"UOC Reumatologia ed immunologia clinica ( Site 1901)","Roma","00168",{"type":50,"coordinates":190},[191,192],11.10642,44.99364,{"lat":192,"lon":191},[195],{"name":57,"role":36,"phone":196,"phoneExt":38,"email":38},"+390630157807",{"facility":198,"status":43,"city":199,"state":200,"zip":201,"country":202,"countryCode":203,"cosmosGeoPoint":38,"geoPoint":38,"contacts":204},"The University of Tokyo Hospital ( Site 0301)","Bunkyo","Tokyo","113-8655","Japan","JP",[205],{"name":57,"role":36,"phone":206,"phoneExt":38,"email":38},"+81-3-3815-5411",{"facility":208,"status":43,"city":209,"state":200,"zip":210,"country":202,"countryCode":203,"cosmosGeoPoint":38,"geoPoint":38,"contacts":211},"Keio University Hospital ( Site 0302)","Shinjyuku","160-8582",[212],{"name":57,"role":36,"phone":213,"phoneExt":38,"email":38},"+81-3-3353-1211",{"facility":215,"status":43,"city":216,"state":38,"zip":217,"country":218,"countryCode":219,"cosmosGeoPoint":220,"geoPoint":224,"contacts":225},"PMSI Republican Clinical Hospital \"T.Mosneaga\" ( Site 1001)","Chisinau","2025","Moldova","MD",{"type":50,"coordinates":221},[222,223],28.85938,47.00902,{"lat":223,"lon":222},[226],{"name":57,"role":36,"phone":227,"phoneExt":38,"email":38},"+37379638895",{"facility":229,"status":43,"city":230,"state":230,"zip":231,"country":232,"countryCode":233,"cosmosGeoPoint":234,"geoPoint":238,"contacts":239},"ARENSIA Clinics ( Site 0902)","Bucharest","011658","Romania","RO",{"type":50,"coordinates":235},[236,237],26.10626,44.43225,{"lat":237,"lon":236},[240],{"name":57,"role":36,"phone":241,"phoneExt":38,"email":38},"40722604155",{"facility":243,"status":43,"city":244,"state":245,"zip":246,"country":232,"countryCode":233,"cosmosGeoPoint":247,"geoPoint":251,"contacts":252},"ARENSIA Exploratory Medicine-Country Emergency Hospital- Arensia,Cluj-Napoca ( Site 0901)","Cluj-Napoca","Cluj","400006",{"type":50,"coordinates":248},[249,250],23.6,46.76667,{"lat":250,"lon":249},[253],{"name":57,"role":36,"phone":254,"phoneExt":38,"email":38},"+40745381603",{"facility":256,"status":43,"city":257,"state":258,"zip":259,"country":260,"countryCode":261,"cosmosGeoPoint":38,"geoPoint":38,"contacts":262},"Chulalongkorn University ( Site 0501)","Pathumwan","Bangkok","10330","Thailand","TH",[263],{"name":57,"role":36,"phone":264,"phoneExt":38,"email":38},"+6622516704",{"type":266,"investigatorFullName":38,"investigatorTitle":38,"investigatorAffiliation":38,"oldNameTitle":38,"oldOrganization":38},"SPONSOR","100620897","phase-1-a-clinical-study-of-mk-1045-in-people-with-lupus-or-rheumatoid-arthritis-mk-1045-004-100620897",false,"NCT07363590","A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)","A Dose Escalation Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MK-1045 in Participants With Systemic Lupus Erythematosus and Rheumatoid Arthritis","Inclusion Criteria:\n\n* Has a body mass index between 18 and 32 kg\u002Fm\\^2, inclusive\n* Systemic lupus erythematosus (SLE): Has a diagnosis of SLE for at least 6 months and met the European Alliance of Associations for Rheumatology (EULAR)\u002F American College of Rheumatology (ACR) 2019 classification criteria\n* SLE: Is taking at least one background therapy for SLE\n* RA: Has a diagnosis of RA for at least 6 months and meets the 2010 ACR-EULAR classification criteria for RA\n\nExclusion Criteria:\n\n* Has a known active infection (excluding fungal infection of nail beds), or any major episode of infection requiring hospitalization or treatment with anti-infectives within 8 weeks prior to the Day 1 dosing\n* History of serious recurrent or chronic infection\n* Is known to be infected with hepatitis B virus, hepatitis C virus, or human immunodeficiency virus\n* Has evidence of active tuberculosis (TB), latent TB, or inadequately treated TB\n* Has a significant or uncontrolled medical disease in any organ system not related to RA or SLE\n* For RA participants, has a history of any arthritis with onset before age 17 years\n* Has a current inflammatory condition other than SLE or RA that could interfere with disease activity assessments\n* History of cancer (except fully treated nonmelanoma skin cancers or cervical carcinoma in situ after complete surgical removal) and is disease free for \\\u003C5 years before Day 1 dosing\n* Has had a major surgery within 3 months prior to Screening or has a major surgery planned during the study.\n* Has symptomatic heart failure (New York Heart Association class III or IV) or myocardial infarction or unstable angina pectoris within 6 months prior to Screening\n* Has a severe chronic pulmonary disease requiring oxygen therapy\n* Has current active lymphoproliferative disease, including lymphoma, or signs and symptoms suggestive of possible lymphoproliferative disease","ALL","18 Years","75 Years",{"count":278,"type":279},21,"ESTIMATED","INTERVENTIONAL",[282],"PHASE1","This study looks at a study medicine called MK-1045 in people with lupus and rheumatoid arthritis (RA). The main goal of the study is to learn about the safety of MK-1045 and if people tolerate it when they receive it at different dose levels (amounts).",[285,286],"Systemic Lupus Erythematosus","Rheumatoid Arthritis","2026-06-19",{"date":289,"type":290},"2026-06-23","ACTUAL",{"date":292,"type":290},"2026-02-19",{"date":294,"type":279},"2029-07-16",{"name":5,"class":6},17]